Raju Prasad serves as Executive at CRISPR Therapeutics AG, where they oversee executive responsibilities. Since joining the company, Raju Prasad has executed 8 insider transactions totaling $2.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 22, 2026 involved exercising options for 34,972 shares valued at $0.
Raju Prasad currently holds 41,667 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Raju Prasad has been a net seller of CRSP stock. They have purchased $0 and sold $2.9M worth of shares.
Raju Prasad's most recent insider trade was on Jan 22, 2026, when they sold 34,972 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $60.19 |
| Discretionary |
| Jan 22, 2026 | CRSP | $1.6M | Option Exercise | 34,972 | $45.15 | Discretionary |
| Dec 22, 2025 | CRSP | $308.2K | Sale | 5,472 | $56.33 | Discretionary |
| Dec 22, 2025 | CRSP | $56.9K | Sale | 1,000 | $56.89 | Discretionary |
| Dec 22, 2025 | CRSP | $194.4K | Sale | 3,528 | $55.10 | Discretionary |
| Mar 15, 2024 | CRSP | $256.2K | Sale | 3,524 | $72.69 | Discretionary |
| Mar 14, 2024 | CRSP | $0 | Option Exercise | 10,000 | $N/A | Discretionary |